UK Vaccine Funding Cuts: Child Deaths Risk | Vaccines
UK funding cuts to Gavi could jeopardize global vaccination efforts, threatening to increase child deaths, experts warn. Sir Andrew Pollard, a key figure in vaccine development, underscores the UK’s crucial role in global health, stressing that reduced investment in multilateral aid could leave the UK more vulnerable to infectious diseases. News Directory 3 highlights how the UK’s potential funding decrease for Gavi, which has vaccinated over a billion children, risks undermining decades of progress. Reduced funding could signal a retreat from leadership, potentially impacting the UK’s ability to respond to future pandemics. Discover what’s next for global health initiatives.
UK Funding Cuts Threaten Global Vaccination Efforts, Experts Warn
Updated June 09, 2025
A potential reduction in United Kingdom funding for the global Alliance for Vaccines and Immunisation (Gavi) is drawing sharp criticism from vaccine and aid experts. They argue that such cuts would not only harm global health but also weaken the UK’s soft power and increase its own vulnerability to infectious diseases.
Sir Andrew Pollard, who spearheaded the Oxford-AstraZeneca COVID-19 vaccine development, is among those voicing concern. He suggests that diminished support for Gavi could compromise the UK’s ability to effectively respond to future pandemics. Gavi, a public-private partnership based in Geneva, has provided vaccinations to over a billion children in developing nations.
Historically, the UK has been a major Gavi benefactor, contributing over £2 billion in the past four years. However, with the UK’s aid budget reduced to 0.3% of gross national income, a notable funding decrease is anticipated. This shift prioritizes bilateral aid, potentially impacting multilateral organizations like Gavi.
Pollard emphasized the dual benefit of supporting global vaccination. ”It’s a safer place, obviously, for people who are in situations where they wouldn’t have been able to access thes vaccines without the government support, but it also makes it a safe place for us, because it’s acting as part of the shield that we have against the spread of infectious diseases around the world,” he said.
He also noted that many vaccines utilized by Gavi, including a new malaria vaccine co-developed by Oxford University, originated in the UK. This highlights the importance of maintaining domestic expertise and infrastructure for rapid pandemic response. “The Covid vaccine was developed on the back of years of funding… so we could than respond when a pandemic happened,” Pollard stated.
Dr. Sandy Douglas, a senior vaccinologist at oxford University’s Jenner Institute, emphasized Gavi’s cost-effectiveness, estimating that it saves a child’s life for every £1,200 spent. “There really aren’t very many ways of spending money anywhere in the world that can save a child’s life for so little money,” Douglas said.
“The withdrawal or reduction of British funding to Gavi is going to result in the avoidable deaths of many children,” Douglas added.
Moazzam Malik, chief executive of Save the Children UK, pointed out the UK’s conventional leadership role in multilateral aid efforts. A reduced commitment, he warned, would signal a retreat from this leadership position.
Gavi reports vaccinating over 1.1 billion children across 78 countries in its 25 years of operation, preventing nearly 19 million deaths through global vaccination.
An FCDO spokesperson stated that global health remains a priority, adding, “Whilst we would not comment on the size of future pledges before announcing them, we continue to work with our partners, including Gavi, on this crucial issue.”
What’s next
The Foreign, Commonwealth and Development Office is expected to release details of its future funding plans soon. The global community will be watching closely to see how the UK balances its domestic priorities with its commitment to global health security and global vaccination.